292 related articles for article (PubMed ID: 18832259)
41. Clinical evaluation of new therapies for treatment of mucus hypersecretion in respiratory diseases.
Disse B
Novartis Found Symp; 2002; 248():254-72; discussion 272-6, 277-82. PubMed ID: 12568499
[TBL] [Abstract][Full Text] [Related]
42. [A new concept for the treatment of patients with acute exacerbations of chronic obstructive pulmonary disease (COPD)].
Ewig S; Schaberg T
Pneumologie; 2006 May; 60(5):295-304. PubMed ID: 16703484
[TBL] [Abstract][Full Text] [Related]
43. Effect of CArbocisteine in Prevention of exaceRbation of chronic obstructive pulmonary disease (CAPRI study): An observational study.
Esposito A; Valentino MR; Bruzzese D; Bocchino M; Ponticiello A; Stanziola A; Sanduzzi A
Pulm Pharmacol Ther; 2016 Apr; 37():85-8. PubMed ID: 26970503
[TBL] [Abstract][Full Text] [Related]
44. Roflumilast for severe COPD?
Drug Ther Bull; 2011 Apr; 49(4):45-8; quiz iii-iv. PubMed ID: 21467576
[TBL] [Abstract][Full Text] [Related]
45. Clinical inquiries: When are antibiotics indicated for acute COPD exacerbations?
Balser E; Neher JO; Safranek S; Taraday J
J Fam Pract; 2006 Dec; 55(12):1079-80. PubMed ID: 17137546
[TBL] [Abstract][Full Text] [Related]
46. Pharmacology and clinical efficacy of erdosteine in chronic obstructive pulmonary disease.
Moretti M
Expert Rev Respir Med; 2007 Dec; 1(3):307-16. PubMed ID: 20477170
[TBL] [Abstract][Full Text] [Related]
47. Efficacy and safety of erdosteine in the treatment of chronic rhinosinusitis with nasal polyposis - a pilot study.
Hoza J; Salzman R; Starek I; Schalek P; Kellnerova R
Rhinology; 2013 Dec; 51(4):323-7. PubMed ID: 24260764
[TBL] [Abstract][Full Text] [Related]
48. [Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: analysis of comparative trials].
Garré M; Garo B; Ansart S; Le Berre R
Med Mal Infect; 2006; 36(11-12):690-6. PubMed ID: 16824719
[TBL] [Abstract][Full Text] [Related]
49. Changes in blood ROS, e-NO, and some pro-inflammatory mediators in bronchial secretions following erdosteine or placebo: a controlled study in current smokers with mild COPD.
Dal Negro RW; Visconti M; Micheletto C; Tognella S
Pulm Pharmacol Ther; 2008; 21(2):304-8. PubMed ID: 17889580
[TBL] [Abstract][Full Text] [Related]
50. Protective role of erdosteine pretreatment on oleic acid-induced acute lung injury.
Erdem A; Gedikli E; Yersal N; Karaismailoglu S; Muftuoglu S; Fadillioglu E; Tuncer M
J Surg Res; 2017 Jun; 213():234-242. PubMed ID: 28601320
[TBL] [Abstract][Full Text] [Related]
51. [Antibiotics for exacerbations of chronic obstructive pulmonary disease].
Lange P
Ugeskr Laeger; 2007 May; 169(19):1780-2. PubMed ID: 17537351
[No Abstract] [Full Text] [Related]
52. Short course of antibiotic treatment in acute exacerbations of COPD.
Wilson R
Thorax; 2008 May; 63(5):390-2. PubMed ID: 18443155
[No Abstract] [Full Text] [Related]
53. Antibacterial therapy of acute infectious exacerbation of chronic obstructive pulmonary disease.
Chelidze K; Jgarkava M
Georgian Med News; 2008 Jun; (159):27-30. PubMed ID: 18633147
[TBL] [Abstract][Full Text] [Related]
54. The problems of meta-analysis for antibiotic treatment of chronic obstructive pulmonary disease, a heterogeneous disease: a commentary on Puhan et al.
Sethi S
BMC Med; 2008 Oct; 6():29. PubMed ID: 18847482
[TBL] [Abstract][Full Text] [Related]
55. Answers to 5 common questions about acute exacerbations of COPD.
Anzueto AR
Postgrad Med; 2009 Sep; 121(5):159-65. PubMed ID: 19820285
[TBL] [Abstract][Full Text] [Related]
56. [Guidelines for the clinical management of COPD. Exacerbations/acute respiratory failure: antibiotherapy].
SPLF. Société de Pneumologie de Langue Française
Rev Mal Respir; 2003 Jun; 20(3 Pt 2):S65-8. PubMed ID: 12910099
[No Abstract] [Full Text] [Related]
57. Reducing airways inflammation to prevent exacerbations in chronic obstructive pulmonary disease.
Roche N; Huchon G
Allergy; 2005 Nov; 60(11):1350-6. PubMed ID: 16197465
[No Abstract] [Full Text] [Related]
58. Preventing exacerbations of chronic bronchitis and COPD: therapeutic potential of mucolytic agents.
Poole PJ; Black PN
Am J Respir Med; 2003; 2(5):367-70. PubMed ID: 14719989
[TBL] [Abstract][Full Text] [Related]
59. Systemic corticosteroids and COPD exacerbations.
Mersfelder TL
Med Health R I; 2005 Aug; 88(8):277-8. PubMed ID: 16273973
[No Abstract] [Full Text] [Related]
60. Erdosteine ameliorates lung injury induced by transient aortic occlusion in rats.
Kurtoglu T; Sacar M; Inan BK; Duver MH; Guler A; Ucak A; Us MH; Yilmaz AT
Cardiovasc J Afr; 2007; 18(6):367-70. PubMed ID: 18092111
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
